EUVIMEDEUVIMED entdecken
Crossref

Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach

Cankat Genis, Cagrı Torun Ozel, Ahmet Selmanoglu, Zeynep Sengul Emeksiz, Emine Dibek Misirlioglu

Allergy and Asthma Proceedings · 2025

DOI: 10.2500/aap.2025.46.250057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy and Asthma Proceedings, 2025. Verfasst von Cankat Genis und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Ondansetron, Antiemetics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ondansetron is a common antiemetic that rarely causes hypersensitivity. Skin-prick testing (SPT) and intradermal testing (IDT) may assist in diagnosing ondansetron hypersensitivity; however, their sensitivity, specificity, and optimal concentrations remain unclear. To our knowledge, drug provocation testing (DPT), the criterion standard for diagnosis, has not been previously applied in pediatric cases.

Objective

In this study, we aimed to evaluate ondansetron hypersensitivity in children by using a preliminary diagnostic approach that incorporated SPT, IDT, and DPT.

Methods

We retrospectively reviewed pediatric patients who were evaluated for suspected ondansetron hypersensitivity between 2019 and 2025. We performed an SPT by using an ondansetron concentration of 2 mg/mL, followed by an IDT with concentrations of 0.02 and 0.2 mg/mL in patients with negative SPT results. In cases of patients with negative skin test results, we conducted DPTs.

Results

We included seven pediatric patients ages 3‐16 years. All had negative SPT results, which underscores its limited sensitivity. IDT results were positive in three patients with a history of anaphylaxis (one at 0.02 mg/mL, two at 0.2 mg/mL); DPT was not performed in these patients. Among the four with negative skin test results, DPT was performed in three and yielded negative results. We confirmed hypersensitivity in three patients. In another three, no clinical reactivity was observed at the time of DPT, and the diagnosis remained inconclusive in one patient.

Conclusion

To our knowledge, this is the first pediatric case series to propose a preliminary diagnostic approach that incorporated DPT in the evaluation of suspected ondansetron hypersensitivity. The findings highlight the limited sensitivity of SPT, emphasize the diagnostic value of IDT, particularly in patients with anaphylaxis, and support the safe applicability of DPT in patients with negative skin test results, with all three DPTs yielding negative results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityOndansetronAntiemeticsHumansChildMaleFemaleChild, PreschoolAdolescentSkin TestsRetrospective StudiesIntradermal TestsSensitivity and SpecificityAnaphylaxis

Substanzen

OndansetronAntiemetics

Zitieren

APA

Genis, C., Torun Ozel, C., Selmanoglu, A., Sengul Emeksiz, Z., & Dibek Misirlioglu, E. (2025). Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach. Allergy and Asthma Proceedings. https://doi.org/10.2500/aap.2025.46.250057

Vancouver

Genis C, Torun Ozel C, Selmanoglu A, Sengul Emeksiz Z, Dibek Misirlioglu E. Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach. Allergy and Asthma Proceedings. 2025. doi:10.2500/aap.2025.46.250057

BibTeX
@article{Genis2025,
  author = {Genis, Cankat and Torun Ozel, Cagrı and Selmanoglu, Ahmet and Sengul Emeksiz, Zeynep and Dibek Misirlioglu, Emine},
  title = {Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach},
  journal = {Allergy and Asthma Proceedings},
  year = {2025},
  doi = {10.2500/aap.2025.46.250057}
}
Kostenlos starten →